Heather Cook

Has grant

Head of Trial Management

University of Exeter

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Heather Cook is the Head of Trial Management at the University of Exeter, UK. Her research focuses on areas including clinical trials in pharmacology, interventions for irritable bowel syndrome, and cancer epigenetics. She is currently involved in several impactful studies, including the evaluation of COVID-19 nursing care guidelines and the development of a centralized pharmacovigilance system in clinical trials.

Recent Grants

Grant: Open

A multi-centre double-blind randomised placebo-controlled group-sequential superiority trial to assess the effectiveness and cost-effectiveness of oral Corticosteroids in patients witH fibrOtic hypeRsensitivity pneUmonitiS (CHORUS).

Open Date: 2024-06-01

Close Date: 2028-05-31

Grant: Open

DEXACELL: Dexamethasone as an adjunctive therapy for the management of cellulitis - a randomised controlled trial in urgent secondary care

Open Date: 2024-01-01

Close Date: 2026-12-31

Grant: Open

Understanding the mechanisms driving the reduction of repetitive negative thought

Open Date: 2024-01-01

Close Date: 2029-12-01

Articles (7)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Collaborators (16)

Siobhan Creanor

University of Plymouth

UNITED KINGDOM

Heather Cook

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (7)

Epigenetic deprogramming by disruption of CIZ1-RNA nuclear assemblies in early-stage breast cancers

Evaluation of a COVID-19 fundamental nursing care guideline versus usual care: The COVID-NURSE cluster randomized controlled trial

Protocol for a feasibility randomised controlled trial of the 'Outdoor' mobility intervention for older adults after hip fracture.

Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT

Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia.

Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial

Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care

Collaborators (16)

Siobhan Creanor

Claire Hulme

David Richards

Susannah Tooze

Stefanny Guerra Ceballos

Christoph Rüegger

Adilia Warris

Emma Godfrey

Elspeth Guthrie

Katie Jane Sheehan

Dawn Coverley

catherine sackley

Jo Thompson Coon

Heather Iles-Smith

Susanne Cruickshank

Emma Stewart

Make your next move.